Ling Chen

1.7k total citations
51 papers, 1.2k citations indexed

About

Ling Chen is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ling Chen has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Physiology, 10 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Ling Chen's work include Pain Mechanisms and Treatments (8 papers), Adipose Tissue and Metabolism (8 papers) and Alzheimer's disease research and treatments (7 papers). Ling Chen is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Adipose Tissue and Metabolism (8 papers) and Alzheimer's disease research and treatments (7 papers). Ling Chen collaborates with scholars based in China, United States and Canada. Ling Chen's co-authors include Steven M. Scharf, Qi Zhang, Jeffrey D. Hasday, C. William Balke, Jeffrey D. Messinger, Christine A. Curcio, Xiaohong Tracey Gan, Guoxi Li, Thomas A. Swain and Gerald McGwin and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Ling Chen

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Chen China 18 455 449 166 163 154 51 1.2k
Abdelrahman Y. Fouda United States 23 498 1.1× 209 0.5× 200 1.2× 157 1.0× 103 0.7× 47 1.4k
Angelo Maffei Italy 26 764 1.7× 592 1.3× 682 4.1× 21 0.1× 82 0.5× 36 2.1k
Yohko Yoshida Japan 23 766 1.7× 600 1.3× 297 1.8× 25 0.2× 98 0.6× 56 1.8k
Martin J. Stevens United States 18 345 0.8× 624 1.4× 369 2.2× 121 0.7× 25 0.2× 23 1.8k
Bindu Pillai United States 22 523 1.1× 162 0.4× 191 1.2× 194 1.2× 35 0.2× 38 1.3k
Kelli A. Sullivan United States 24 546 1.2× 1.1k 2.3× 135 0.8× 37 0.2× 29 0.2× 29 2.2k
Miguel Flores‐Bellver United States 16 606 1.3× 174 0.4× 33 0.2× 228 1.4× 33 0.2× 27 1.2k
Valeriy V. Lyzogubov United States 19 503 1.1× 566 1.3× 43 0.3× 343 2.1× 18 0.1× 36 1.5k
Enrique Alborch Spain 26 538 1.2× 568 1.3× 216 1.3× 22 0.1× 126 0.8× 93 1.8k
Dieu‐Trang Fuchs United States 19 387 0.9× 609 1.4× 54 0.3× 387 2.4× 33 0.2× 34 1.4k

Countries citing papers authored by Ling Chen

Since Specialization
Citations

This map shows the geographic impact of Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Chen more than expected).

Fields of papers citing papers by Ling Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Chen. The network helps show where Ling Chen may publish in the future.

Co-authorship network of co-authors of Ling Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Chen. A scholar is included among the top collaborators of Ling Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Chen. Ling Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaodi, Ling Chen, Lianfeng Lu, et al.. (2025). Single-cell multi-omics profiling uncovers the immune heterogeneity in HIV-infected immunological non-responders. EBioMedicine. 115. 105667–105667. 4 indexed citations
2.
Xu, Lang, Zhengtao Jiang, Lin Chen, et al.. (2025). Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity. Redox Biology. 85. 103737–103737. 3 indexed citations
4.
Shi, Changcheng, Yingying Yang, Limin Wang, et al.. (2024). Guidance Documents for Off‐Label Drug Use Management for Chinese Health Care Institutions: A Scoping Review. Journal of Evidence-Based Medicine. 17(4). 808–821.
5.
Qian, Kun, Jingyan Zhou, Qing Wang, et al.. (2024). Discovery of a novel KV7.2/7.3 channels agonist for the treatment of neuropathic pain. European Journal of Medicinal Chemistry. 280. 116953–116953. 3 indexed citations
6.
Chen, Ling, et al.. (2021). Nogo-A Induced Polymerization of Microtubule Is Involved in the Inflammatory Heat Hyperalgesia in Rat Dorsal Root Ganglion Neurons. International Journal of Molecular Sciences. 22(19). 10360–10360. 4 indexed citations
8.
Zeng, Li, Ling Lin, Ling Chen, Wenjun Xiao, & Zhihua Gong. (2021). l‐Theanine Ameliorates d‐Galactose‐Induced Brain Damage in Rats via Inhibiting AGE Formation and Regulating Sirtuin1 and BDNF Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2021(1). 8850112–8850112. 28 indexed citations
9.
Xu, Wenshuai, Lu Zhang, Yu Li, et al.. (2020). Effects of yoga on exercise capacity in patients with lymphangioleiomyomatosis: a nonrandomized controlled study. Orphanet Journal of Rare Diseases. 15(1). 72–72. 8 indexed citations
10.
Li, Jinyang, Ling Chen, Liye Shi, et al.. (2020). Hemoglobin, Albumin and Cholesterol as Potential Malnutrition Risk Biomarkers Associated with Coronary Artery Disease in Older People: A Cross-Sectional Analysis. International journal of gerontology. 14(4). 260–264. 1 indexed citations
11.
Zhang, Xiaoyu, Xiaowei Gao, Ling Chen, et al.. (2019). Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice. Neuropharmacology. 162. 107783–107783. 13 indexed citations
12.
Zhang, Wen, Dan Shen, Yun Li, et al.. (2019). A novel peptide RIFV suppresses human adipocyte differentiation through the inhibition of C/EBP-β expression. Nutrition & Metabolism. 16(1). 88–88. 5 indexed citations
13.
Zhang, Jinghua, Linjie Yu, Hui Yang, et al.. (2018). Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition. BMC Complementary and Alternative Medicine. 18(1). 167–167. 13 indexed citations
14.
Chen, Tingting, Chonghui Wang, Guoxi Li, et al.. (2016). Atorvastatin in improvement of cognitive impairments caused by amyloid β in mice: involvement of inflammatory reaction. BMC Neurology. 16(1). 18–18. 24 indexed citations
15.
Yang, Pei, Jinquan Cai, Wei Yan, et al.. (2016). Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas. Neuro-Oncology. 18(8). 1099–1108. 86 indexed citations
16.
Jin, Jiali, Anthony K. F. Liou, Yejie Shi, et al.. (2015). CART treatment improves memory and synaptic structure in APP/PS1 mice. Scientific Reports. 5(1). 10224–10224. 39 indexed citations
17.
Zhu, Xiaolei, Lan Ye, Hui Ming Ge, et al.. (2012). Hopeahainol A attenuates memory deficits by targeting β‐amyloid in APP/PS1 transgenic mice. Aging Cell. 12(1). 85–92. 23 indexed citations
18.
Shi, Chunmei, Guangfeng Xu, Lei Yang, et al.. (2012). Overexpression of TFAM Protects 3T3-L1 Adipocytes from NYGGF4 (PID1) Overexpression-Induced Insulin Resistance and Mitochondrial Dysfunction. Cell Biochemistry and Biophysics. 66(3). 489–497. 11 indexed citations
19.
Chen, Ling, et al.. (2005). Oxidative Stress and Left Ventricular Function with Chronic Intermittent Hypoxia in Rats. American Journal of Respiratory and Critical Care Medicine. 172(7). 915–920. 191 indexed citations
20.
Chen, Ling, Anthony L. Sica, Harly Greenberg, & Steven M. Scharf. (1998). Role of hypoxemia and hypercapnia in acute cardiovascular response to periodic apneas in sedated pigs. Respiration Physiology. 111(3). 257–269. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026